Generics Bulletin is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Pfizer Inc.

http://www.pfizer.com

Latest From Pfizer Inc.

Obesity Gold Rush To Drive Significant Spending Growth Through Decade, IQVIA Says

IQVIA’s latest usage and spending trends report forecasts US obesity market will grow to $35bn by 2028, while the two leading GLP-1 agonists have already posted eye-popping sales growth.

Pricing Debate Metabolic Disorders

BioNTech Ramps Up Spending To Launch 10 Pivotal Cancer Studies In 2024

As COVID-19 vaccine sales decline, the company is investing billions in a diverse oncology pipeline including antibody drug conjugates, immunotherapy and cancer vaccines

Clinical Trials Commercial

Stock Watch: Core Business Drags As Roche Disappoints And Sanofi Reclassifies

After the volatility of pandemic-related sales, investor and analyst attention turned to pharma’s core businesses. With exclusivity losses weighing on those large components of pharma, Sanofi’s reclassification may bring some unwelcome attention.

Stock Watch Sales & Earnings

Pfizer Takes A Hit On US Oncology Biosimilars In Q1

Pfizer has reported US oncology biosimilars sales that were down by 47% in the first quarter of 2024, as pricing pressures took their toll.

Sales & Earnings Biosimilars
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Other Names / Subsidiaries
    • Agouron Pharmaceuticals
    • Alpharma Pharmaceuticals LLC
    • American Home Products
    • Amplyx Pharmaceuticals, Inc.
    • Anacor Pharmaceuticals, Inc.
    • Array BioPharma, Inc. (ARRY)
    • Arixa Pharmaceuticals, Inc. Bamboo Therapeutics, Inc.
    • Bioren, Inc,
    • Coley Pharmaceutical Group, Inc.
    • CovX Pharmaceuticals, Inc
    • C.P. Pharmaceuticals International C.V.
    • Encysive Pharmaceuticals
    • Excaliard
    • FoldRx Pharmaceuticals, Inc.
    • Ferrosan Consumer Health
    • GD Searle
    • Hisun-Pfizer Pharmaceuticals Co., Ltd.
    • Hospira, Inc.
    • Icagen, Inc.
    • Idun Pharmaceuticals, Inc.
    • InnoPharma
    • Javelin Pharmaceuticals, Inc.
    • King Pharmaceuticals, Inc.
    • Lederle Laboratories
    • Mayne Pharma Limited
    • Meridica Limited
    • Neusentis
    • Parke-Davis
    • Pharmacia
    • Pharmacia and Upjohn Co.
    • PHT Pharma S.r.l.
    • Powdermed
    • Redvax GmbH
    • ReViral Ltd.
    • Serenex
    • Strato Medical Corp.
    • SUGEN
    • Texas Biothechnology Corporation
    • Thiakis Limited
    • Vicuron Pharmaceuticals
    • ViiV Healthcare
    • Warner-Lambert
    • Wyeth
    • Wyeth-Ayerst Laboratories, Inc.
    • Treerly Health Co., Ltd.
    • Meridian Medical Technologies Inc.
    • Montreal, Inc.
    • Medivation, Inc.
    • Sugen LLC
    • Therachon Holding AG.
    • Jones Pharma Inc.
    • Trillium Therapeutics Inc.
UsernamePublicRestriction

Register